An Investment Outlook: Looking forward to 2021

Richard Moore – Co head of Investments 2020 impacted businesses both large and small. Covid-19 and government mandated lockdowns created a very uncertain economic outlook and companies across the board took measures to strengthen balance sheets and preserve cash. The … Continued

Arecor’s partner Inhibrx to license first formulation

Arecor has announced that partner Inhibrx Inc. is to license a novel enhanced formulation of its proprietary therapeutic candidate, INBRX-101, developed by Arecor using the Company’s patented technology, Arestat™. This is the first license under a multi-product development agreement between two companies with … Continued